Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda to divest dry eye drug to Novartis in $5.3bn deal

pharmaceutical-technologyMay 10, 2019

Tag: Takeda , Novartis , Dry , eye , Drug

PharmaSources Customer Service